Patent application number | Description | Published |
20080311146 | Immunogenic Composition - The present invention discloses an immunogenic composition comprising at least two different isolated staphylococcal polypeptides, each comprising an IgG binding domain. In a further embodiment, the invention discloses a polypeptide comprising: a protein A part including at least one IgG binding domain and an Sbi part including at least one IgG binding domain. | 12-18-2008 |
20110008385 | Immunogenic composition - The present application relates to immunogenic compositions comprising staphylococcal PNAG and Type 5 and/or 8 capular polysaccharide or oligosaccharide from | 01-13-2011 |
20120141523 | IMMUNOGENIC COMPOSITION COMPRISING ANTIGENIC S. AUREUS PROTEINS - The present application relates to an immunogenic composition comprising a fragment of a staphylococcal Isd protein such as IsdA, IsdB, IsdC or IsdH which comprises a NEAT domain. Fusion proteins comprising a NEAT domain of a first staphylococcal Isd protein and a NEAT domain from a second Isd protein are also disclosed as well as fusion proteins comprising a NEAT domain of a staphylococcal Isd protein involved in an iron/heme uptake system and a ligand binding domain of a staphylococcal extracellular component binding protein, for example ClfA, ClfB, SdrC, SdrD or SdrE. | 06-07-2012 |
20130004530 | VACCINE COMPOSITION - Neisserial immunogenic compositions and vaccines, their manufacture and methods for the use of such compositions in medicine are provided herein. | 01-03-2013 |
20130011429 | IMMUNOGENIC COMPOSITION - Immunogenic compositions and methods of their use, as well as processes for their production are provided herein. | 01-10-2013 |
20130045231 | IMMUNOGENIC COMPOSITION - Compositions for the treatment or prevention of Neisserial infection and methods for their use and manufacture are provided herein. | 02-21-2013 |
20140093529 | IMMUNOGENIC COMPOSITION - The present invention relates to fusion proteins comprising fragments of toxin A and toxin B from | 04-03-2014 |
20140178424 | IMMUNOGENIC COMPOSITION - The present invention relates to fusion proteins comprising fragments from toxin A and/or toxin B of | 06-26-2014 |